Journal Article Summary
The article investigates the trends and demographic differences in the use of medications and lifestyle counseling for patients with atherosclerotic cardiovascular disease (ASCVD) in the United States from 2006 to 2016. This topic is significant because ASCVD is a leading cause of death and disability, and effective secondary prevention strategies, including statin therapy, aspirin prescriptions, and lifestyle counseling, are crucial for improving patient outcomes. The study also examines the impact of the 2013 American College of Cardiology and American Heart Association guidelines, which aimed to enhance treatment practices for ASCVD.
The researchers analyzed data from the National Ambulatory Medical Care Survey, focusing on 11,033 visits by adults with ASCVD. They found that while there was a slight increase in the prescription of statins and aspirin following the new guidelines, the overall rates of these treatments remained low, with less than half of patients receiving them. Additionally, lifestyle counseling services decreased during the study period, and disparities persisted, with women and Black patients less likely to receive these preventive measures compared to their male and White counterparts.
The study has several limitations, including potential underreporting of lifestyle counseling and a lack of data on patient adherence to treatments. It also does not account for updates in guidelines beyond 2016 or explore the reasons behind the observed disparities. Patients should discuss these findings with their healthcare providers to understand their individual risk factors and treatment options, as well as to address any barriers to receiving appropriate care for ASCVD.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Mufarreh Anthony, Shah Amit J., Vaccarino Viola, Kulshreshtha Ambar. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016. JAMA Network Open 2023. DOI: 10.1001/jamanetworkopen.2022.51156. PMID: 36656581. PMCID: PMC9857274.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
